[
  {
    "ts": "2026-02-06T14:26:52+00:00",
    "headline": "Have originator medicines’ list prices started to drop in the US?",
    "summary": "According to the GlobalData service Price Intelligence (POLI) & HTA, more than 800 originator molecules still posted price hikes to their WACs and AWPs.",
    "url": "https://www.pharmaceutical-technology.com/pricing-and-market-access/originator-medicines-list-prices-us/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "66d45b55-caef-3c59-863f-d09779d22c24",
      "content": {
        "id": "66d45b55-caef-3c59-863f-d09779d22c24",
        "contentType": "STORY",
        "title": "Have originator medicines’ list prices started to drop in the US?",
        "description": "",
        "summary": "According to the GlobalData service Price Intelligence (POLI) & HTA, more than 800 originator molecules still posted price hikes to their WACs and AWPs.",
        "pubDate": "2026-02-06T14:26:52Z",
        "displayTime": "2026-02-06T14:26:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/bf1fa2ea791c2e3cb4b7e84cd6c3edfd",
          "originalWidth": 1440,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KbF2uPBSK_ONCiufO6cBBg--~B/aD0xMDgwO3c9MTQ0MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/pharmaceutical_technology_376/bf1fa2ea791c2e3cb4b7e84cd6c3edfd.cf.webp",
              "width": 1440,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ruavv5LUUmT0_kvaAJhw5Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/bf1fa2ea791c2e3cb4b7e84cd6c3edfd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/pricing-and-market-access/originator-medicines-list-prices-us/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/originator-medicines-list-prices-started-142652063.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SNY"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-06T05:01:00+00:00",
    "headline": "Top Picks 2026- AbbVie Inc. ABBV",
    "summary": "AbbVie Inc. (ABBV) is a US-based biopharmaceutical company formed in 2013 as a spinoff from Abbott Laboratories (ABT). It’s a cutting-edge company with strong exposure to high-demand needs in immunology and oncology...and it has a terrific pipeline, maintains Tom Hutchinson, editor of Cabot Dividend Investor.",
    "url": "https://finance.yahoo.com/news/top-picks-2026-abbvie-inc-050100557.html",
    "source": "MoneyShow",
    "provider": "yfinance",
    "raw": {
      "id": "6dd4b7d9-0699-37a2-a358-331e91e40e89",
      "content": {
        "id": "6dd4b7d9-0699-37a2-a358-331e91e40e89",
        "contentType": "STORY",
        "title": "Top Picks 2026- AbbVie Inc. ABBV",
        "description": "",
        "summary": "AbbVie Inc. (ABBV) is a US-based biopharmaceutical company formed in 2013 as a spinoff from Abbott Laboratories (ABT). It’s a cutting-edge company with strong exposure to high-demand needs in immunology and oncology...and it has a terrific pipeline, maintains Tom Hutchinson, editor of Cabot Dividend Investor.",
        "pubDate": "2026-02-06T05:01:00Z",
        "displayTime": "2026-02-06T05:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/moneyshow_610/5c1c7a9d7b2118d461c2dafd218cddae",
          "originalWidth": 666,
          "originalHeight": 349,
          "caption": "chart",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5GRU7Has4Af_RscjEVT7lQ--~B/aD0zNDk7dz02NjY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneyshow_610/5c1c7a9d7b2118d461c2dafd218cddae.cf.webp",
              "width": 666,
              "height": 349,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nyOQ_SpfbeAMTrKyo7WV9g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneyshow_610/5c1c7a9d7b2118d461c2dafd218cddae.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MoneyShow",
          "url": "https://www.moneyshow.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-picks-2026-abbvie-inc-050100557.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-picks-2026-abbvie-inc-050100557.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]